Increased levels of IL-10, IL-12, and IFN-γ in patients with visceral leishmaniasis

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 1, 2009, Pages 44-46

  Khoshdel, Abolfazl ^a   Alborzi, A ^b   Rosouli, M ^b   Taheri, E ^a   Kiany, S ^b   Javadian, M H ^b  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Interferon; Interleukin; Visceral leishmaniasis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; BIOLOGICAL MARKER;

ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DATA ANALYSIS; ENDEMIC DISEASE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; KRUSKAL WALLIS TEST; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; RANK SUM TEST; SKIN TEST; VISCERAL LEISHMANIASIS; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; NONPARAMETRIC TEST; SIBLING;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; LEISHMANIASIS, VISCERAL; MALE; SIBLINGS; STATISTICS, NONPARAMETRIC;

EID: 69249229871     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000100010     Document Type: Article

References (25)

1. World Health organization. Control of leishmaniasis. Report of a WHO Expert committee. Technical Report Series, Geneva, Switzerland, 1991.
2. Caldas A., Favali C., Aquino D., et al. Balance of IL10 and interferon - gamma plasma levels in human visceral leishmaniasis: Implications in the pathogenesis. BioMed central infectious disease 2005;5:113.
3. Edrisian G.H., Nadim A., Alborzi A., Ardehali S. Visceral leishmaniasis; the Iranian experience. Archive Iranian Medical Journal 1998; 1:22-6.
4. Nadim A., Navid-Hamidid A., Javadian E., et al. Present status of kalaazar in Iean. Am J Trop Med Hyg 1978;27(1 p+1):25-8.
5. Pearson R.D., Sousa A.Q. A clinical spectrum of leishmaniasis. Clinical Infectious Disease 1996;22:1-3.
6. Choudhary A., A. Puri, P.Y. Guru, K.C. Saxena. An indirect fluorescent Antibody (IFA) test for the serodiagnosis of kalaazar. Journal of Communicable Disease 1992;24:32-6.
7. Barral A., Costa J.M., Bittencourt A.L., et al. Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects. Int Dermatol 1995;34(7):474-9.
8. Holaday B. Role of CD8+ T cell in endogenous interleukin -10 secretion associated with visceral leishmaniasis. Memorias do Instituto oswaldo cruz 2000;95:217-20.
9. Liew F., Millott S., Parkinson C., et al. Macrophage killing of leishmania parasites in vivo is mediated by nitric oxide from Larginine. Journal of Immunology 1990;144:4794-7.
10. Ghalib H., wittle J., Kubin M. IL-12 enhances Th1-type responses in human leishmania donovani infections. Journal of immunology 1995; 154:4623-9.
11. Ribeiro Jesus A., Almeida R.P., Lessa H., et al. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998; 31:143-8.
12. Badaro R., Jones T.C., Carvalho E.M., et al. New perspectives on a subclinical form of visceral leishmaniasis. J infect Dis 1986; 154:1003-11.
13. Hailu A., Vander Poll T., Berhe N., Kager P.A. Elevated plasma level of interferon (IFN) - gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis. American journal of Tropical Medicine Hygiene 2004;71:561-5.
14. Cenini P., Berhe N., Hailu A., et al. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J Infect Dis 1993;168:986-93.
15. Van der Poll T., Zijlstra E.E., Merissen M. Interleukin 6 during active visceral leishmaniasis and after treatment. Clin Immunol Immunopathol 1995,77:111-4.
16. Sundar S., Reed S.G., Sharma S., et al. circulating T helper 1 (Th1) cell and Th2 cell - associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 1997;56:522-5.
17. Barral-Netto M., Badaro R., Barral A., et al. Tumor Necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis 1991; 163:853-7.
18. M.E.A Gama, J.M.L. Costa, J.C.R. Pereira, et al. Serum cytokine profile in subclinical form of visceral leishmaniasis Braz J Med Biol Res 2004;37(1)129-36.
19. Caldas A., Favali C., Aquino D., et al. Balance of IL-10 and interferon -ã plasma levels in human visceral leishmaniasis: implications in the pathogenesis BCM infect Dis 2005;5:113-21.
20. Heizel F.P., Sadick M.D., Mutha S.S., Locksley R.M. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. proc Natl Acad Sci USA 1991;88:7011-5.
21. Scot P. IFN- gamma modulates the early development of T1 and Th2 responses in a murine model of cutaneous leishmaniasis. J immunol 1991;147:3149-55.
22. De Medeiros I.M., Castelo A., Salomao R. presence of circulating levels of interferon - gamma, interleukin - 10 and tumor necrosis factor - alpha in patients with visceral leishmaniasis. Rev inst Med Trop Sao Paulo 1998;40:31-4.
23. Carvalho E.M., Bacellar O., Brownell C., et al. Restoration of IFN- gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 1994;152:5949-56.
24. Cillari E., Vitale G., Arcoleo F., et al. In vivo and in vitro cytokine profiles and mono- nuclear cell subsets in sicillian patients with active visceral leishmaniasis. Cytokine 1995; 7:740-5.
25. Zwingenberger K., Harms G., Pedrosa G., et al. Determinats of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin -4 over interferon -ã production. Clin immunol immunopathol 1990;57:242-9.